SLGC
Somalogic Inc
19.10$
-0.4%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.1% | -20.6% | -13.8% | -79.1% | -63.2% | -17.9% | -189.6% | -83.9% | -184.4% | -211.2% | -128.2% | -96.9% | -153.4% | |
| 2.6% | 3.7% | 3.4% | 2.7% | 2.9% | 3.3% | 6.8% | 2.8% | 8.9% | 8.6% | 9.2% | 8.6% | 8.8% | |
| 18.9% | 17.2% | 24.1% | 63.4% | 33.6% | 37.7% | 66.9% | 40.5% | 45.6% | 35.2% | 21.0% | 18.2% | 29.5% | |
| – | 137.1% | 81.3% | -11.7% | 12.4% | -87.6% | -100.6% | 30.7% | 195.2% | 30.6% | 20.3% | – | – | |
| -23.6% | 6.1% | 19.4% | -22.4% | 22.5% | 81.8% | 74.5% | -38.5% | 78.1% | -76.9% | -38.2% | -16.1% | -15.1% | |
| 1.7% | 1.0% | 3.9% | 10.3% | 16.1% | 9.4% | 37.6% | 10.6% | 35.4% | 6.2% | 5.5% | 3.6% | 12.1% | |
| -143.1% | -401.3% | 17.7% | -490.9% | -65.6% | 24.2% | 23.4% | -5.4% | 403.2% | 271.3% | -283.2% | -125.1% | 55.9% | |
| – | 1,474.0% | – | 410.2% | 5.0% | 5.4% | 25.8% | – | 1.6% | 0.8% | 1.2% | – | – | |
| – | -193.6% | -184.6% | -182.6% | – | – | – | – | – | – | – | – | – | |
| 635.8% | 3.3% | -197.6% | 2,678.8% | 1.8% | 5.4% | 25.8% | 11.7% | 1.6% | 0.8% | 1.2% | 0.0% | 0.9% | |
| 490.6% | -418.7% | -193.7% | 2,108.7% | -127.1% | 11.7% | -140.5% | -89.4% | 220.4% | 60.8% | -410.2% | -222.1% | -96.7% | |
| -3.7% | -21.6% | -17.7% | -89.4% | -79.3% | -27.3% | -227.2% | -94.5% | -149.0% | -217.4% | -133.7% | -100.5% | -149.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.